TY - JOUR
T1 - Tumour-associated macrophages correlate with poor prognosis in myxoid liposarcoma and promote cell motility and invasion via the HB-EGF-EGFR-PI3K/Akt pathways
AU - Nabeshima, A.
AU - Matsumoto, Y.
AU - Fukushi, J.
AU - Iura, K.
AU - Matsunobu, T.
AU - Endo, M.
AU - Fujiwara, T.
AU - Iida, K.
AU - Fujiwara, Y.
AU - Hatano, M.
AU - Yokoyama, N.
AU - Fukushima, S.
AU - Oda, Y.
AU - Iwamoto, Y.
N1 - Funding Information:
We thank Dr Junji Kishimoto for helpful suggestions on statistics. This work was supported by a Grant-in-Aid for Scientific Research (23592192, 25293325, and 26713046) from the Japan Society for the Promotion of Science, and a Grant-in-Aid for Clinical Research Evidence-Based Medicine and Cancer Research from the Ministry of Health, Labour and Welfare of Japan (Y Iwamoto).
Publisher Copyright:
© 2015 Cancer Research UK. All rights reserved 0007 - 0920/15.
PY - 2015/2/3
Y1 - 2015/2/3
N2 - Background:Myxoid liposarcoma (MLS) is the second most common subtype of liposarcoma, and metastasis occurs in up to one-third of cases. However, the mechanisms of invasion and metastasis remain unclear. Tumour-associated macrophages (TAMs) have important roles in tumour invasion, metastasis, and/or poor prognosis. The aim of this study was to investigate the relationship between TAMs and MLS.Methods:Using 78 primary MLS samples, the association between clinical prognosis and macrophage infiltration was evaluated by immunochemistry. The effects of macrophages on cell growth, cell motility, and invasion of MLS cell lines were investigated in vitro. In addition, clinicopathological factors were analysed to assess their prognostic implications in MLS.Results:Higher levels of CD68-positive macrophages were associated with poorer overall survival in MLS samples. Macrophage-conditioned medium enhanced MLS cell motility and invasion by activating epidermal growth factor receptor (EGFR), with the key ligand suggested to be heparin-binding EGF-like growth factor (HB-EGF). The phosphoinositide 3-kinase/Akt pathway was mostly involved in HB-EGF-induced cell motility and invasion of MLS. The expression of phosphorylated EGFR in MLS clinical samples was associated with macrophage infiltration. In addition, more significant macrophage infiltration was associated with poor prognosis even in multivariate analysis.Conclusions:Macrophage infiltration in MLS predicts poor prognosis, and the relationship between TAMs and MLS may be a new candidate for therapeutic targets of MLS.
AB - Background:Myxoid liposarcoma (MLS) is the second most common subtype of liposarcoma, and metastasis occurs in up to one-third of cases. However, the mechanisms of invasion and metastasis remain unclear. Tumour-associated macrophages (TAMs) have important roles in tumour invasion, metastasis, and/or poor prognosis. The aim of this study was to investigate the relationship between TAMs and MLS.Methods:Using 78 primary MLS samples, the association between clinical prognosis and macrophage infiltration was evaluated by immunochemistry. The effects of macrophages on cell growth, cell motility, and invasion of MLS cell lines were investigated in vitro. In addition, clinicopathological factors were analysed to assess their prognostic implications in MLS.Results:Higher levels of CD68-positive macrophages were associated with poorer overall survival in MLS samples. Macrophage-conditioned medium enhanced MLS cell motility and invasion by activating epidermal growth factor receptor (EGFR), with the key ligand suggested to be heparin-binding EGF-like growth factor (HB-EGF). The phosphoinositide 3-kinase/Akt pathway was mostly involved in HB-EGF-induced cell motility and invasion of MLS. The expression of phosphorylated EGFR in MLS clinical samples was associated with macrophage infiltration. In addition, more significant macrophage infiltration was associated with poor prognosis even in multivariate analysis.Conclusions:Macrophage infiltration in MLS predicts poor prognosis, and the relationship between TAMs and MLS may be a new candidate for therapeutic targets of MLS.
UR - http://www.scopus.com/inward/record.url?scp=84964284448&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84964284448&partnerID=8YFLogxK
U2 - 10.1038/bjc.2014.637
DO - 10.1038/bjc.2014.637
M3 - Article
C2 - 25562433
AN - SCOPUS:84964284448
SN - 0007-0920
VL - 112
SP - 547
EP - 555
JO - British Journal of Cancer
JF - British Journal of Cancer
IS - 3
ER -